Search Reports

Showing search results for "All"

Below you can search for shortage and discontinuation reports that have been submitted for drug products by a company.

For more information on how to search reports, see “How to Search” section in the Website overview for public users, found in the About & Resources page.

The “Export results” button on the search reports page will create individual CSV files for shortage reports and discontinuation reports containing data from the search results. Please note that the two CSV files will be downloaded in a single .zip file. Users would then need to open the .zip file to access the CSV files.

To search by product, please refer to the Search Product page.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Access the API here.

The export is also available for download through an extract zip file that is updated monthly. Access the Monthly Report extract here.

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

To
Select from the options in the checkboxes/dropdown menu below to filter your results by report type.
Filter by reports that have been designated Tier 3 by Health Canada. Learn more
Select from the options in the checkboxes/dropdown menu below to filter your results by status type

Status Brand name Company Name Strength(s) Date Updated View Report
Actual shortage OPTIRAY 320 (ULTRAJECT) LIEBEL-FLARSHEIM COMPANY LLC 68% 2025-04-30 241513
Actual shortage OPTIRAY 320 LIEBEL-FLARSHEIM COMPANY LLC 68% 2025-04-30 170402
Actual shortage OPTIRAY 320 LIEBEL-FLARSHEIM COMPANY LLC 68% 2025-04-30 170406
Actual shortage OPTIRAY 320 LIEBEL-FLARSHEIM COMPANY LLC 68% 2025-04-30 170411
Resolved OPTIRAY 320 (ULTRAJECT) LIEBEL-FLARSHEIM COMPANY LLC 68% 2020-02-05 97485
Resolved OPTIRAY 320 (ULTRAJECT) LIEBEL-FLARSHEIM COMPANY LLC 68% 2020-02-05 97489
Resolved ZINCOFAX KNIGHT THERAPEUTICS INC. 69% 15% 2019-10-25 93576
Resolved VIRAZOLE BAUSCH HEALTH, CANADA INC. 6G 2025-02-13 247043
Resolved CEFTAZIDIME FOR INJECTION, USP FRESENIUS KABI CANADA LTD 6G 2022-05-24 158759
Discontinued FORTAZ GLAXOSMITHKLINE INC 6G 2020-12-22 130600
Resolved CEFTAZIDIME FOR INJECTION BP STERIMAX INC 6G 2025-12-03 254004
Resolved VIRAZOLE BAUSCH HEALTH, CANADA INC. 6G 2022-09-27 155206
Resolved CEFTAZIDIME FOR INJECTION BP STERIMAX INC 6G 2017-05-25 8810
Resolved VIRAZOLE BAUSCH HEALTH, CANADA INC. 6G 2023-11-01 193926
Resolved VIRAZOLE BAUSCH HEALTH, CANADA INC. 6G 2021-08-12 134795
Resolved CEFTAZIDIME FOR INJECTION BP STERIMAX INC 6G 2022-07-12 162221
Resolved CEFTAZIDIME FOR INJECTION BP STERIMAX INC 6G 2024-09-21 236208
Resolved FORTAZ - INJ 6G/VIAL GLAXOSMITHKLINE INC 6G 2020-12-22 4301
Resolved VIRAZOLE BAUSCH HEALTH, CANADA INC. 6G 2024-01-29 213468
To be discontinued VIRAZOLE BAUSCH HEALTH, CANADA INC. 6G 2025-11-18 272123

Showing 25821 to 25840 of 27806